Clinical Trial Update: Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Update on a Phase 2 trial evaluating the combination of Casodex (bicalutamide) and Iressa (gefitinib) for locally advanced prostate cancer; the study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Casodex (bicalutamide)
• Iressa (gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Locally Advanced Prostate Cancer | Phase 2 | Status: COMPLETED